Ultra-high ferritin, pneumococcal vaccination risk review, diffuse lymphadenopathy and safe assessment of paediatric limp.
An ultra-high ferritin in an acutely unwell patient is a diagnostic alarm, not a result to file under “inflammation”.
Today’s briefing links diagnostic reasoning with infection and paediatric safety-netting. In an immunosuppressed patient with severe midline back pain, systemic symptoms, swollen red eye, vesicular rash, cytopenias, liver injury and shock, an ultra-high ferritin should be actively explained rather than dismissed as a non-specific inflammatory marker. Secondary HLH is a syndrome that requires a trigger search, not an endpoint diagnosis. Disseminated herpesvirus infection, malaria, dengue, salmonella, typhus, malignancy and autoimmune disease all remain relevant when an immunosuppressed returning traveller deteriorates.
Diffuse lymphadenopathy adds a second diagnostic reasoning thread. Retroperitoneal and inguinal nodes should be interpreted through location, distribution, symptoms, blood tests and imaging pattern before biopsy. Normal inflammatory markers and absence of B symptoms do not exclude lymphoma when deep abdominal nodes are present. Biopsy planning should balance safety with diagnostic yield, rather than defaulting to the easiest node.
Infection prevention appears through pneumococcal disease. Streptococcus pneumoniae can cause otitis media, sinusitis, pneumonia, sepsis and meningitis, with invasive disease defined by isolation from a sterile site such as blood or cerebrospinal fluid. Vaccination review is especially important in older adults and people with asplenia, immunosuppression, CSF leak, cochlear implant, chronic kidney disease, diabetes or chronic respiratory disease. The 2026 UK adult strategy moves attention towards PCV20 and the practical need to document vaccine type, date and indication.
Paediatric care brings two transition points. A child with hip pain, groin pain, limp or refusal to walk may have transient synovitis, especially after viral illness, but only if the child is otherwise well, afebrile and has reassuring observations. Fever, systemic illness, worsening pain or failure to improve within 48–72 hours should prompt urgent reassessment for septic arthritis or other pathology. Young adults with epilepsy also need planned transition from paediatric to adult neurology, with clinical information and expectations prepared before the first adult appointment.
Critical-care, haematology and infectious-diseases clinicians get a diagnostic reasoning case around ultrahyperferritinaemia, suspected secondary HLH, disseminated herpesvirus infection, cytopenias, liver injury, DIC and shock in an immunosuppressed patient with lupus nephritis. It emphasises red-flag back pain, diagnostic pivots, returning-traveller infection work-up and avoiding anchoring on autoimmune flare.
Haematology, oncology and medical-education readers get a structured approach to diffuse retroperitoneal and inguinal lymphadenopathy. The episode links clinical-radiographic mismatch, blood-test diagnoses before biopsy, high-yield tissue sampling, indolent lymphoma and professional boundaries when diagnostic uncertainty affects family.
Primary-care, respiratory and infectious-diseases clinicians get a practical pneumococcal disease update. It covers capsule biology, serotype diversity, invasive pneumococcal disease, pneumonia, sepsis, meningitis, adult risk groups and the 2026 UK shift towards PCV20 for adults aged 65 years and over and clinically at-risk groups.
Neurology, paediatric and adolescent-health teams get a concise care-transition update for young adults with epilepsy. It frames transition as clinical preparation rather than simple referral, with patient expectations, emotional uncertainty, medication review, seizure history and adult-service readiness all included in the handover.
Paediatric, emergency and orthopaedic clinicians get a focused review of hip pain, groin pain, limp and refusal to walk in children aged 3–10 years. Transient synovitis is linked to recent viral illness, but septic arthritis, fracture, fever, systemic illness and failure to improve remain key safety-net triggers.
When back pain occurs in an immunosuppressed patient, document red flags including severe midline pain, systemic symptoms, neurological compromise, recent procedures, rash and eye findings. For ferritin above 10,000 with cytopenias or liver injury, involve haematology and infectious diseases early while searching for infection, malignancy and autoimmune triggers. In paediatric limp, record temperature, observations, general appearance and weight-bearing ability before using transient synovitis as the working diagnosis.
An immunosuppressed patient has severe midline back pain, vesicular rash, eye inflammation, cytopenias, acute liver injury and ferritin above 30,000 micrograms/L. What diagnostic frame should be used?
Consider secondary HLH or hyperinflammatory physiology, then actively search for the trigger. Disseminated HSV, VZV or CMV should remain high on the differential when rash, eye disease and hepatitis occur in a T-cell immunosuppressed patient.
A well-looking older adult has diffuse retroperitoneal and inguinal lymphadenopathy with normal inflammatory markers and no B symptoms. What is the main diagnostic caution?
Normal inflammatory markers and absent B symptoms do not exclude lymphoma. Node distribution, anatomical location, blood-test diagnoses and safe high-yield biopsy planning should guide the next step.
A 5-year-old has hip pain and limp after a recent viral illness, is afebrile, has normal observations and can weight bear with discomfort. What follow-up and safety-netting are required?
Treat symptoms with simple analgesia when appropriate and arrange review within 48–72 hours to confirm improvement. Advise urgent reassessment for fever, systemic illness, worsening pain, inability to weight bear or failure to improve, because septic arthritis and fracture must not be missed.
.svg)